Related references
Note: Only part of the references are listed.Is physiological glucocorticoid replacement important in children?
John Porter et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Health Care Burden in Patients With Adrenal Insufficiency
Candace Gunnarsson et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study
Henrik Falhammar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Henrik Falhammar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Henrik Falhammar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Thang S. Han et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Long-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
Mouna Feki Mnif et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
Incidence and clinical features of congenital adrenal hyperplasia in Great Britain
Javaria Mona Khalid et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2012)
Adult women with 21-hydroxylase deficient congenital adrenal hyperplasia, surgical and psychological aspects
Anna Nordenstrom
CURRENT OPINION IN PEDIATRICS (2011)
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Emily Herrett et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Validity of diagnostic coding within the General Practice Research Database: a systematic review
Nada F. Khan et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2010)
Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients
Wiebke Arlt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Sexual Function and Surgical Outcome in Women with Congenital Adrenal Hyperplasia Due to CYP21A2 Deficiency: Clinical Perspective and the Patients' Perception
Anna Nordenstrom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
Sudeep Karve et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: The Leipzig experience
Wolfgang Hoepffner et al.
HORMONE RESEARCH (2008)
How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?
Scott D. Grosse et al.
HORMONE RESEARCH (2007)
Quality of life in 70 women with disorders of sex development
Trine H. Johannsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Methods for evaluation of medication adherence and persistence using automated databases
Susan E. Andrade et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Long term psychological outcome for women with congenital adrenal hyperplasia: cross sectional survey
JF Morgan et al.
BRITISH MEDICAL JOURNAL (2005)
Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology
S Berenbaum et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty
S Krege et al.
BJU INTERNATIONAL (2000)